Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 40MEQ versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 40MEQ versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and fluid, correcting hypoglycemia. Sodium chloride and potassium chloride replenish electrolytes and maintain osmotic balance.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion: 1000 mL administered at a rate of 125 mL/hour over 8 hours; typical dosing range 1-3 L per 24 hours titrated based on electrolyte levels, fluid status, and clinical response.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
The components do not have a classical half-life. Dextrose has a distribution half-life of a few minutes and an elimination half-life of approximately 1-2 hours due to cellular uptake and metabolism. Sodium and chloride have a volume-dependent half-life; potassium's elimination half-life is approximately 12-24 hours, prolonged in renal impairment.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is metabolized to carbon dioxide and water, with negligible renal excretion. Sodium and chloride are primarily excreted renally, with >90% eliminated unchanged; potassium is >90% renally excreted, with minor fecal (approximately 5%) and negligible biliary elimination.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte